Acquiring Company
Eli Lilly and Company
Acquired Company
Centessa Pharmaceuticals
Description
Eli Lilly and Company has finalized its acquisition of Centessa Pharmaceuticals, which will enhance Lilly's ability to innovate treatments for sleep-wake disorders. This move aligns with Lilly's ongoing commitment to tackle health issues related to sleep. The acquisition follows a report of significant revenue growth for Lilly, reflecting the success of its products and strategies.
Don't miss Eli Lilly and Company's next move
Get an email the moment Eli Lilly and Company makes an acquisition, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Centessa Pharmaceuticals?
Centessa Pharmaceuticals was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on August 13, 2026. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is privately held and operates in Biotechnology.
When did Eli Lilly and Company acquire Centessa Pharmaceuticals?
Eli Lilly and Company's acquisition of Centessa Pharmaceuticals was reported on August 13, 2026. Eli Lilly and Company has finalized its acquisition of Centessa Pharmaceuticals, which will enhance Lilly's ability to innovate treatments for sleep-wake disorders. This move aligns with Lilly's ongoing commitment to tackle health issues related to sleep. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Centessa Pharmaceuticals do?
Centessa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients. It aims to harness the power of science to bring together specialists to address serious diseases. It is privately held, operating in Biotechnology, and is based in Boston.